Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Viganò

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Neurochemistry|October 18, 2000
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940T Rubino, D Viganò, P Massi, et al.
The European Journal of Neuroscience|September 29, 2001
The psychoactive ingredient of marijuana induces behavioural sensitizationT Rubino, D Viganò, P Massi, et al.
The European Journal of Neuroscience|January 25, 2003
Cellular mechanisms of Delta 9-tetrahydrocannabinol behavioural sensitizationT Rubino, D Viganò, P Massi, et al.
Synapse (New York, N.Y.)|December 1, 1999
In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatmentsT Rubino, D Viganò, E Zagato, et al.
Journal of Neurochemistry|November 18, 2000
Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant ratsT Rubino, D Viganò, B Costa, et al.
European Journal of Pharmacology|January 29, 2000
Relative involvement of cannabinoid CB(1) and CB(2) receptors in the Delta(9)-tetrahydrocannabinol-induced inhibition of natural killer activityP Massi, D Fuzio, D Viganò, et al.
Life Sciences|June 2, 2000
Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndromeT Rubino, P Massi, D Viganò, et al.
Neuroreport|November 14, 1997
Modulation of rat brain cannabinoid receptors after chronic morphine treatmentT Rubino, L Tizzoni, D Viganò, et al.
Current Drug Targets|December 19, 2009
Cellular mechanisms underlying the interaction between cannabinoid and opioid systemD Parolaro, T Rubino, D Viganò, et al.
Neuroscience|March 26, 2003
Mu opioid receptor signaling in morphine sensitizationD Viganò, T Rubino, G Di Chiara, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Neurochemistry|October 18, 2000
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940T Rubino, D Viganò, P Massi, et al.
The European Journal of Neuroscience|September 29, 2001
The psychoactive ingredient of marijuana induces behavioural sensitizationT Rubino, D Viganò, P Massi, et al.
The European Journal of Neuroscience|January 25, 2003
Cellular mechanisms of Delta 9-tetrahydrocannabinol behavioural sensitizationT Rubino, D Viganò, P Massi, et al.
Synapse (New York, N.Y.)|December 1, 1999
In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatmentsT Rubino, D Viganò, E Zagato, et al.
Journal of Neurochemistry|November 18, 2000
Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant ratsT Rubino, D Viganò, B Costa, et al.
European Journal of Pharmacology|January 29, 2000
Relative involvement of cannabinoid CB(1) and CB(2) receptors in the Delta(9)-tetrahydrocannabinol-induced inhibition of natural killer activityP Massi, D Fuzio, D Viganò, et al.
Life Sciences|June 2, 2000
Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndromeT Rubino, P Massi, D Viganò, et al.
Neuroreport|November 14, 1997
Modulation of rat brain cannabinoid receptors after chronic morphine treatmentT Rubino, L Tizzoni, D Viganò, et al.
Current Drug Targets|December 19, 2009
Cellular mechanisms underlying the interaction between cannabinoid and opioid systemD Parolaro, T Rubino, D Viganò, et al.
Neuroscience|March 26, 2003
Mu opioid receptor signaling in morphine sensitizationD Viganò, T Rubino, G Di Chiara, et al.
Pageof 2